Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series
Cancer Treatment and Research Communications · 2023
DOI: 10.1016/j.ctarc.2023.100731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2023. Verfasst von Niloufar Hoorshad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Carcinoma, Endometrioid, Ovarian Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Obstetrics and Gynecology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Gynecology Oncology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: dr.narges.zamani@gmail.com.
Zitieren
APA
Hoorshad, N., Nassiri, S., Najibi, S., Feizabad, E., & Zamani, N. (2023). Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2023.100731
Vancouver
Hoorshad N, Nassiri S, Najibi S, Feizabad E, Zamani N. Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series. Cancer Treatment and Research Communications. 2023. doi:10.1016/j.ctarc.2023.100731
BibTeX
@article{Hoorshad2023,
author = {Hoorshad, Niloufar and Nassiri, Saina and Najibi, Shaparak and Feizabad, Elham and Zamani, Narges},
title = {Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series},
journal = {Cancer Treatment and Research Communications},
year = {2023},
doi = {10.1016/j.ctarc.2023.100731}
}
EUVIMED